These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6599484)

  • 1. Symposium on the renin-angiotensin-aldosterone system: treatment of hypertension and heart failure. Satellite symposium of the First European Meeting on Hypertension. 28 May 1983, Milan, Italy.
    J Hypertens Suppl; 1983 Oct; 1(1):1-159. PubMed ID: 6599484
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin system and the heart. Proceedings of a satellite symposium to the Third European Meeting on Hypertension. June 13, 1987, Milan, Italy.
    Am J Med; 1988 Mar; 84(3A):1-162. PubMed ID: 3218650
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal function and the renin-angiotensin system. Satellite symposium of the Fourth European Meeting on Hypertension. 17 June 1989, Milan, Italy. Proceedings.
    J Hypertens Suppl; 1989 Sep; 7(7):S1-67. PubMed ID: 2614543
    [No Abstract]   [Full Text] [Related]  

  • 4. Symposium on the sympathetic nervous system in the pathogenesis, complications and treatment of hypertension. Satellite symposium of the Second European Meeting on Hypertension. 13 June 1985, Milan, Italy.
    J Hypertens Suppl; 1985 Dec; 3(4):S1-105. PubMed ID: 3868708
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the opportunities for blocking the renin-angiotensin system: introduction to a special supplement.
    Weber MA
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S1-6. PubMed ID: 17401311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
    Laragh JH
    J Hum Hypertens; 1995 Jun; 9(6):385-90. PubMed ID: 7473515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symposium on serotonin and cardiovascular regulation: a new approach to hypertension. Satellite symposium of the Second European Meeting on Hypertension. 9 June 1985, Milan, Italy.
    J Hypertens Suppl; 1986 Apr; 4(1):S1-111. PubMed ID: 2939207
    [No Abstract]   [Full Text] [Related]  

  • 10. Symposium on decision-making in the management of hypertension. Satellite symposium of the Second European Meeting on Hypertension. 8 June 1985, Milan, Italy.
    J Hypertens Suppl; 1985 Nov; 3(2):S1-159. PubMed ID: 3866838
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
    Radzevich AE; Ditiatkov AE; Tikhonov VA
    Probl Tuberk; 2001; (5):16-9. PubMed ID: 11588951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternative pathways of angiotensin I. The glimpse of new possibilities in the treatment of hypertension and heart failure].
    Francischetti EA
    Arq Bras Cardiol; 1995 Mar; 64(3):191-4. PubMed ID: 7487502
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium transport, blood pressure regulation and treatment of hypertension. Satellite symposium of the Third European Meeting on Hypertension. 12 June 1987, Milan, Italy.
    J Hypertens Suppl; 1987 Dec; 5(4):S1-145. PubMed ID: 3481631
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive treatment of the active elderly patient. Satellite symposium to the 4th European Meeting on Hypertension. Milan, Italy, June 17, 1989. Proceedings.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S1-62. PubMed ID: 2483565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Direct renin inhibition: a new and promising treatment principle in heart failure?].
    Mahfoud F; Ukena C; Böhm M
    Dtsch Med Wochenschr; 2009 Apr; 134(15):759-62. PubMed ID: 19340755
    [No Abstract]   [Full Text] [Related]  

  • 16. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
    Abassi Z; Winaver J; Feuerstein GZ
    Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.